Development and External Validation of an Extended 10-Core Biopsy Nomogram

European Urology

Volumn 52, Issue 2, 2007, Pages 436-445

  Chun, Felix K H ^a,b   Briganti, Alberto ^a,c   Graefen, Markus ^b   Montorsi, Francesco ^c   Porter, Christopher ^d   Scattoni, Vincenzo ^c   Gallina, Andrea ^a,c   Walz, Jochen ^b   Haese, Alexander ^b   Steuber, Thomas ^b   Erbersdobler, Andreas ^e   Schlomm, Thorsten ^b   Ahyai, Sascha A ^b   Currlin, Eike ^b   Valiquette, Luc ^a   Heinzer, Hans ^b   Rigatti, Patrizio ^c   Huland, Hartwig ^b   Karakiewicz, Pierre I ^a  

^a UNIVERSITÉ DE MONTRÉAL   (Canada)

^b UNIVERSITY OF HAMBURG   (Germany)

^c VITA SALUTE SAN RAFFAELE UNIVERSITY   (Italy)

^d VIRGINIA MASON MEDICAL CENTER   (United States)

^e UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

Author keywords

Extended initial prostate biopsy; Nomogram; Prostate cancer; Validation

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADULT; AGED; ARTICLE; CANCER DIAGNOSIS; CONTROLLED STUDY; DIAGNOSTIC ACCURACY; DIGITAL RECTAL EXAMINATION; EXTERNAL VALIDITY; GERMANY; HUMAN; INTERNAL VALIDITY; MAJOR CLINICAL STUDY; MALE; MASS SCREENING; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; NOMOGRAM; PRIORITY JOURNAL; PROSTATE CANCER;

ADULT; AGED; AGED, 80 AND OVER; AREA UNDER CURVE; BIOPSY, NEEDLE; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; NOMOGRAMS; PROSTATIC NEOPLASMS; ROC CURVE;

EID: 34250744756     PISSN: 03022838     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.eururo.2006.08.039     Document Type: Article

References (30)

1. Hodge K.K., McNeal J.E., Terris M.K., et al. Random systematic versus directed ultrasound guided transrectal core biopsies of the prostate. J Urol 142 (1989) 71-74
2. Carlson G.D., Calvanese C.B., and Partin A.W. An algorithm combining age, total prostate-specific antigen (PSA), and percent free PSA to predict prostate cancer: results on 4298 cases. Urology 52 (1998) 455-461
3. Eastham J.A., May R., Robertson J.L., et al. Development of a nomogram that predicts the probability of a positive prostate biopsy in men with an abnormal digital rectal examination and a prostate-specific antigen between 0 and 4 ng/mL. Urology 54 (1999) 709-713
4. Potter S.R., Horniger W., Tinzl M., et al. Age, prostate-specific antigen, and digital rectal examination as determinants of the probability of having prostate cancer. Urology 57 (2001) 1100-1104
5. Djavan B., Remzi M., Zlotta A., et al. Novel artificial neural network for early detection of prostate cancer. J Clin Oncol 20 (2002) 921-929
6. Garzotto M., Hudson R.G., Peters L., et al. Predictive modeling for the presence of prostate carcinoma using clinical, laboratory, and ultrasound parameters in patients with prostate specific antigen levels ≤10 ng/mL. Cancer 98 (2002) 1417-1422
7. Garzotto M., Beer T.M., Hudson R.G., et al. Improved detection of prostate cancer using classification and regression tree analysis. J Clin Oncol 23 (2005) 4322-4329
8. Karakiewicz P.I., Benayoun S., Kattan M.W., et al. Development and validation of a nomogram predicting the outcome of prostate biopsy based on patient age, digital rectal examination and serum prostate specific antigen. J Urol 173 (2005) 1930-1934
9. Eskew L.A., Bare R.L., and McCullough D.L. Systematic 5 region prostate biopsy is superior to sextant method for diagnosing carcinoma of the prostate. J Urol 157 (1997) 199-202
10. Norberg M., Egevad L., Holmberg L., et al. The sextant protocol for ultrasound-guided core biopsies of the prostate underestimates the presence of cancer. Urology 50 (1997) 562-566
11. Levine M.A., Ittman M., Melamed J., et al. Two consecutive sets of transrectal ultrasound guided sextant biopsies of the prostate for the detection of prostate cancer. J Urol 159 (1998) 471-475
12. Eskew L.A., Woodruff R.D., Bare R.L., et al. Prostate cancer diagnosed by the 5 region biopsy method is significant disease. J Urol 160 (1998) 794-796
13. Chang J.J., Shinohara K., Bhargava V., et al. Prospective evaluation of lateral biopsies of the peripheral zone for prostate cancer detection. J Urol 160 (1998) 2111-2114
14. Presti Jr. J.C., Chang J.J., Bhargava V., et al. The optimal systematic prostate biopsy scheme should include 8 rather than 6 biopsies: results of a prospective clinical trial. J Urol 163 (2000) 163-166
15. Carroll P.R. Prostate biopsy: a wealth of information when done and interpreted correctly. J Clin Oncol 18 (2000) 1161-1163
16. Chan T.Y., Chan D.Y., Stutzman K.L., et al. Does increased needle biopsy sampling of the prostate detect a higher number of potentially insignificant tumors?. J Urol 166 (2001) 2181-2184
17. Gore J.L., Shariat S.F., Miles B.J., et al. Optimal combinations of systematic sextant and laterally directed biopsies for the detection of prostate cancer. J Urol 165 (2001) 1554-1559
18. Singh H., Canto E.I., Shariat S.F., et al. Improved detection of clinically significant, curable prostate cancer with systematic 12-core biopsy. J Urol 171 (2004) 1089-1092
19. Singh H., Canto E.I., Shariat S.F., et al. Six additional systematic lateral cores enhance sextant biopsy prediction of pathological features at radical prostatectomy. J Urol 171 (2004) 204-209
20. Canto E.I., Singh H., Shariat S.F., et al. Effects of systematic 12-core biopsy on the performance of percent free prostate specific antigen for prostate cancer detection. J Urol 172 (2004) 900-904
21. Thompson I.M., Pauler D.K., Goodman P.J., et al. Prevalence of prostate cancer among men with a prostate-specific antigen level ≤4.0 ng per milliliter. N Engl J Med 350 (2004) 2239-2246
22. Uzzo R.G., Wei J.T., Waldbaum R.S., et al. The influence of prostate size on cancer detection. Urology 46 (1995) 831-836
23. Karakiewicz P.I., Bazinet M., Aprikian A.G., et al. Outcome of sextant biopsy according to gland volume. Urology 49 (1997) 55-59
24. Vashi A.R., Wojno K.J., Gillespie B., et al. A model for the number of cores per prostate biopsy based on patient age and prostate gland volume. J Urol 159 (1998) 920-924
25. Applewhite J.C., Matlaga B.R., and McCullough D.L. Results of the 5 region prostate biopsy method: the repeat biopsy population. J Urol 168 (2002) 500-503
26. Eskicorapci S.Y., Guliyev F., Akdogan B., et al. Individualization of the biopsy protocol according to the prostate gland volume for prostate cancer detection. J Urol 173 (2005) 1536-1540
27. Matlaga B.R., Eskew L.A., and McCullough D.L. Prostate biopsy: indications and technique. J Urol 169 (2003) 12-19
28. Aus G., Abbou C.C., Bolla M., et al. EAU guidelines on prostate cancer. Eur Urol 48 (2005) 546-551
29. Tombal B. Over- and underdiagnosis of prostate cancer: the dangers. Eur Urol Suppl 5 (2006) 511-513
30. Rocco B., de Cobelli O., Leon M.E., et al. Sensitivity and detection rate of a 12-core trans-perineal prostate biopsy: preliminary report. Eur Urol 49 (2006) 827-833